Orphazyme A/S Price Chart
Orphazyme A/S 1TBD.F Financial and Trading Overview
| Orphazyme A/S stock price | 1.07 EUR |
| Previous Close | 1.07 EUR |
| Open | 1.07 EUR |
| Bid | 0.48 EUR x N/A |
| Ask | 1.1 EUR x N/A |
| Day's Range | 1.07 - 1.07 EUR |
| 52 Week Range | 0.96 - 26.6 EUR |
| Volume | 1.31K EUR |
| Avg. Volume | 108 EUR |
| Market Cap | 37.78M EUR |
| Beta (5Y Monthly) | 0.342145 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.411 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1 EUR |
1TBD.F Valuation Measures
| Enterprise Value | -4679902 EUR |
| Trailing P/E | N/A |
| Forward P/E | -0.65243906 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.90677977 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.167 |
Trading Information
Orphazyme A/S Stock Price History
| Beta (5Y Monthly) | 0.342145 |
| 52-Week Change | -85.34% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 26.6 EUR |
| 52 Week Low | 0.96 EUR |
| 50-Day Moving Average | 1.11 EUR |
| 200-Day Moving Average | 2.51 EUR |
1TBD.F Share Statistics
| Avg. Volume (3 month) | 108 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 35.31M |
| Float | 25.8M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.032% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.28% |
| Return on Equity (ttm) | -150.22% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -28028000 EUR |
| Net Income Avi to Common (ttm) | -38312000 EUR |
| Diluted EPS (ttm) | -2.411 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 42.46M EUR |
| Total Cash Per Share (mrq) | 1.2 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.553 |
| Book Value Per Share (mrq) | 1.18 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -117945000 EUR |
| Levered Free Cash Flow (ttm) | -64086624 EUR |
Profile of Orphazyme A/S
| Country | Germany |
| State | N/A |
| City | Copenhagen |
| Address | Ole Maaløes Vej 3 |
| ZIP | 2200 |
| Phone | 45 70 70 29 80 |
| Website | https://www.orphazyme.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 1 |
Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.
Q&A For Orphazyme A/S Stock
What is a current 1TBD.F stock price?
Orphazyme A/S 1TBD.F stock price today per share is 1.07 EUR.
How to purchase Orphazyme A/S stock?
You can buy 1TBD.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Orphazyme A/S?
The stock symbol or ticker of Orphazyme A/S is 1TBD.F.
How many shares does Orphazyme A/S have in circulation?
The max supply of Orphazyme A/S shares is 35.31M.
What is Orphazyme A/S Price to Earnings Ratio (PE Ratio)?
Orphazyme A/S PE Ratio is now.
What was Orphazyme A/S earnings per share over the trailing 12 months (TTM)?
Orphazyme A/S EPS is -2.411 EUR over the trailing 12 months.